Report error Found 25 Enz. Inhib. hit(s) with all data for entry = 50006592
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 4.60nMAssay Description:Antagonist activity at human PPAR-alpha assessed as inhibition of GW7647-induced effect after overnight incubation by cell-based luciferase reporter ...More data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 6.40nMAssay Description:Inhibition of human Nav1.6 assessed as 10 Hz block by patch-clamp electrophysiology/cell based assayMore data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 8.60nMAssay Description:Inhibition of human Nav1.8 assessed as tonic block using double pulse protocol by patch-clamp electrophysiology/cell based assayMore data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 8.80nMAssay Description:Inhibition of human Nav1.6 assessed as inactivated-state block by patch-clamp electrophysiology/cell based assayMore data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 8.90nMAssay Description:Inhibition of human Nav1.8 assessed as 10 Hz block using double pulse protocol by patch-clamp electrophysiology/cell based assayMore data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Antagonist activity at human PPAR-alpha assessed as inhibition of GW7647-induced effect after overnight incubation by cell-based luciferase reporter ...More data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:Inhibition of human Nav1.7 assessed as tonic block by patch-clamp electrophysiology/cell based assayMore data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:Antagonist activity at human PPAR-alpha assessed as inhibition of GW7647-induced effect after overnight incubation by cell-based luciferase reporter ...More data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:Inhibition of human Nav1.8 assessed as tonic block using double pulse protocol by patch-clamp electrophysiology/cell based assayMore data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of human Nav1.6 assessed as 10 Hz block by patch-clamp electrophysiology/cell based assayMore data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of human Nav1.7 assessed as 10 Hz block by patch-clamp electrophysiology/cell based assayMore data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Inhibition of human Nav1.8 assessed as 10 Hz block using double pulse protocol by patch-clamp electrophysiology/cell based assayMore data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 18nMAssay Description:Inhibition of human Nav1.8 assessed as inactivated-state block using double pulse protocol by patch-clamp electrophysiology/cell based assayMore data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 21nMAssay Description:Inhibition of human Nav1.7 assessed as 10 Hz block by patch-clamp electrophysiology/cell based assayMore data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 22nMAssay Description:Inhibition of human Nav1.7 assessed as inactivated-state block by patch-clamp electrophysiology/cell based assayMore data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 23nMAssay Description:Inhibition of human Nav1.7 assessed as inactivated-state block by patch-clamp electrophysiology/cell based assayMore data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 27nMAssay Description:Antagonist activity at human PPAR-alpha assessed as inhibition of GW7647-induced effect after overnight incubation by cell-based luciferase reporter ...More data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 32nMAssay Description:Inhibition of human Nav1.8 assessed as inactivated-state block using double pulse protocol by patch-clamp electrophysiology/cell based assayMore data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 34nMAssay Description:Inhibition of human Nav1.7 assessed as tonic block by patch-clamp electrophysiology/cell based assayMore data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 70nMAssay Description:Inhibition of chymotrypsin-like activity of 26S proteasome in intact human Karpas 1106p cells assessed as substrate hydrolysis using Suc-LLVY-(D)-ami...More data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 75nMAssay Description:Antagonist activity at human PPAR-alpha assessed as inhibition of GW7647-induced effect after overnight incubation by cell-based luciferase reporter ...More data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 307nMAssay Description:Inhibition of BACE1 (unknown origin) by cell-based assayMore data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 320nMAssay Description:Inhibition of chymotrypsin-like activity of 26S proteasome in intact human Karpas 1106p cells assessed as substrate hydrolysis using Suc-LLVY-(D)-ami...More data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human Nav1.6 assessed as inactivated-state block by patch-clamp electrophysiology/cell based assayMore data for this Ligand-Target Pair
TargetReplicase polyprotein 1ab(2019-nCoV)
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Shanghai CureGene Pharmaceutical Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of BACE1 (unknown origin) by cell-based assayMore data for this Ligand-Target Pair
























